These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31382146)

  • 61. The impact of migration-related characteristics on the risk of TORCH infections among women of childbearing age: a population-based study in southern China.
    Li R; Han L; Xiong W; Wang W; Fan C; Li M; Liu X; Ling L
    BMC Public Health; 2023 Feb; 23(1):351. PubMed ID: 36797787
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Association between maternal infections during pregnancy and congenital defects in their offspring: a population-based case-control study in Bogota and Cali, Colombia 2001-2018.
    Rumbo J; Madariaga-P I; Salazar-Reviakina A; Sierra-Breton M; Tovar C; Sequera D; Rodríguez C; Holguín J; Hurtado-Villa P; Sarmiento K; Zarante I
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8723-8727. PubMed ID: 34749588
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immune status in congenital infections by TORCH agents in pregnant Thais.
    Taechowisan T; Sutthent R; Louisirirotchanakul S; Puthavathana P; Wasi C
    Asian Pac J Allergy Immunol; 1997 Jun; 15(2):93-7. PubMed ID: 9346273
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Intrauterine and perinatal viral infections. A review of experiences and remaining problems.
    Pettay O
    Ann Clin Res; 1979 Dec; 11(6):258-66. PubMed ID: 232831
    [No Abstract]   [Full Text] [Related]  

  • 65. The relationship between TORCH complex false positivity and obstetric outcome in patients with antiphospholipid syndrome.
    De Carolis S; Santucci S; Botta A; Salvi S; Degennaro VA; Garufi C; Garofalo S; Ferrazzani S; Scambia G
    Lupus; 2012 Jun; 21(7):773-5. PubMed ID: 22635229
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prevalence of Serum Antibodies to TORCH Infection in and Around Varanasi, Northern India.
    Sen MR; Shukla BN; Tuhina B
    J Clin Diagn Res; 2012 Nov; 6(9):1483-5. PubMed ID: 23285435
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Toxoplasmosis and important virus infections in pregnancy-- diagnosis and management].
    Enders G
    Immun Infekt; 1992 Dec; 20(6):181-8. PubMed ID: 1337060
    [TBL] [Abstract][Full Text] [Related]  

  • 68. How to use... neonatal TORCH testing.
    de Jong EP; Vossen AC; Walther FJ; Lopriore E
    Arch Dis Child Educ Pract Ed; 2013 Jun; 98(3):93-8. PubMed ID: 23470252
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Outcome of gestation of 32 pregnant women with toxoplasma and cytomegalovirus infection].
    Pan CW; Lin FG; Zhang ZY; Liu QZ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1992; 10(3):219-21. PubMed ID: 1339146
    [TBL] [Abstract][Full Text] [Related]  

  • 70. ELISA and TORCH complex: a comparison with the customary tests.
    Ferrucci M; Zavarini A
    Quad Sclavo Diagn; 1982 Sep; 18(3):258-67. PubMed ID: 6306715
    [No Abstract]   [Full Text] [Related]  

  • 71. Placentitis, with a new light on an old ToRCH.
    Altshuler G
    Obstet Gynecol Annu; 1977; 6():197-221. PubMed ID: 200872
    [No Abstract]   [Full Text] [Related]  

  • 72. Should we expand the TORCH complex? A description of clinical and diagnostic aspects of selected old and new agents.
    Kinney JS; Kumar ML
    Clin Perinatol; 1988 Dec; 15(4):727-44. PubMed ID: 2850128
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immune status to congenital infections by TORCH agents in pregnant Saudi women.
    Hossain A; Bakir TM; Ramia S
    J Trop Pediatr; 1986 Apr; 32(2):83-6. PubMed ID: 3012108
    [No Abstract]   [Full Text] [Related]  

  • 74. Prevalence of a positive TORCH and parvovirus B19 screening in pregnancies complicated by polyhydramnios.
    Pasquini L; Seravalli V; Sisti G; Battaglini C; Nepi F; Pelagalli R; Di Tommaso M
    Prenat Diagn; 2016 Mar; 36(3):290-3. PubMed ID: 26970557
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The use of TORCH titers.
    Leland D; French ML; Kleiman MB; Schreiner RL
    Pediatrics; 1983 Jul; 72(1):41-3. PubMed ID: 6306545
    [TBL] [Abstract][Full Text] [Related]  

  • 76. TORCH syndrome.
    Epps RE; Pittelkow MR; Su WP
    Semin Dermatol; 1995 Jun; 14(2):179-86. PubMed ID: 7640200
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Infection of the fetus and the newborn: prevention, treatment and related handicap.
    Rudd P; Peckham C
    Baillieres Clin Obstet Gynaecol; 1988 Mar; 2(1):55-71. PubMed ID: 2843313
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Relationship of rubella, herpes simplex, cytomegalovirus, and certain other viral disabilities.
    Vernon M; Hicks D
    Am Ann Deaf; 1980 Aug; 125(5):529-34. PubMed ID: 6251710
    [No Abstract]   [Full Text] [Related]  

  • 79. Intrauterine viral infections.
    Sever J; White LR
    Annu Rev Med; 1968; 19():471-86. PubMed ID: 4172728
    [No Abstract]   [Full Text] [Related]  

  • 80. Infective diseases during pregnancy and their teratogenic effects.
    Chiodo F; Verucchi G; Mori F; Attard L; Ricchi E
    Ann Ist Super Sanita; 1993; 29(1):57-67. PubMed ID: 8129273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.